Skip to main content
. 2020 May 1;10(5):1534–1547.

Table 2.

Hazard ratios for TRS and major clinical factors

Characteristic Univariate analysis Multivariate analysis


HR 95% CI P HR 95% CI P
Transcriptomic risk
    Low Ref Ref Ref Ref Ref Ref
    Intermediate 4.94 1.16 to 21.1 0.03 4.75 1.07 to 21.1 0.04
    High 43.7 10.2 to 186 < 0.001 44.8 8.62 to 233 < 0.001
Stage
    I Ref Ref Ref Ref Ref Ref
    II 0.66 0.28 to 1.52 0.33 0.36 0.0841 to 1.56 0.17
    III 1.23 0.58 to 2.63 0.59 0.42 0.0547 to 3.27 0.41
    IV 6.22 2.89 to 13.4 < 0.001 28.1 3.73 to 212 0.001
Grade
    1 Ref Ref Ref
    2 1.06 0.25 to 4.47 0.94 Not included
    3 1.01 0.23 to 4.34 0.99
Lymph Node Status
    Negative Ref Ref Ref Ref Ref Ref
    Positive 2.16 1.03 to 4.55 0.043 2.92 1.32 to 6.44 0.008
HHS Vulnerability Disclosure